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Association of particles of lipoprotein
subclasses with arterial stiffness in a high-
risk working population: the Baptist
Employee Healthy Heart Study (BEHHS)
Muhammad Aziz1,2,3, Swetha Gannarapu2, Choudhry Humayun2, Usman Siddiqui2, Khurram Nasir2,4,5 and
Ehimen C. Aneni2,6*
Abstract
Background: Arterial stiffness is an independent predictor of cardiovascular disease (CVD) morbidity and mortality.
A risk factor-independent association of arterial stiffness with traditional lipids has been described extensively, but it
is still unclear whether an independent relationship exists between arterial stiffness and particles of lipoprotein
subclasses.
Methods: The Baptist Employee Healthy Heart Study (BEHHS) is a lifestyle intervention study examining the effects
of web-based programs on reducing CVD risk in high-risk persons. Participants had their brachial arterial
augmentation index (AI, a measure arterial stiffness) assessed using the EndoPAT 2000 device. Cardio IQ™ ion
mobility lipoprotein fractionation was utilized for measurement of particles of lipoprotein subclasses.
Results: The population consisted of 182 participants, (74% women, 49% Hispanic) with a mean age of 52 ± 9
years. There was a significant trend association between quartiles of AI and total cholesterol, HDL-c, large LDL-p,
small IDL-p, large IDL-p, and all subclasses of HDL particles (total HDL-p, small HDL-p, and large HDL-p). In logistic
regression analysis, only HDL-c, total LDL-p, large LDL-p, small IDL-p, large IDL-p, total HDL-p, small HDL-p, and
large HDL-p demonstrated significant independent association with AI.
Conclusion: Several lipoprotein subclasses demonstrate independent significant associations with arterial stiffness.
A safe and relatively inexpensive blood test may be useful in identifying subclinical atherosclerosis process in a
relatively young high CVD risk population.
Trial registration: ClinicalTrials.gov, NCT01912209. Registered July 31, 2013
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Research highlights
 Cardio IQ™ ion mobility lipoprotein fractionation is
a better estimate of particles of lipid subclasses as
compared to traditional lipid measurement.
 This study is a step toward determining the true
relationship between advanced lipid panel (particles
of lipoprotein subclasses) and augmentation index, a
measure of arterial stiffness.
 Several lipoprotein subclasses demonstrated
independent significant associations with arterial
stiffness.
Background
Arterial stiffness, an age-related irreversible hardening of
vessels, is associated with CVD-related morbidity and
mortality [1–4]. Arterial stiffness can be measured by
augmentation index (AI) and pulse wave velocity (PWV)
that represent as measure of wave reflection and arterial
stiffness [5, 6]. AI increases with age and is closely asso-
ciated with CVD risk factors such as hypertension and
coronary artery disease [7, 8]. It also reflects properties
of cardiac performance and overall ventricular-vascular
coupling [4, 9, 10]. Brachial artery AI is a measure of
both central and peripheral arterial stiffness [6, 11].
The association of arterial stiffness with traditional
lipids, such as total cholesterol (TC), triglycerides (TG),
low-density lipoprotein cholesterol (LDL-c), and high-
density lipoprotein cholesterol (HDL-c), has been de-
scribed in cross-sectional studies among high-risk popula-
tion [12, 13]. However, the relationship between arterial
stiffness and particles of lipoprotein subclasses has been
rarely studied. The aim of this study is to determine the
relationship between traditional lipids and lipoprotein
subclasses (measured by the ion mobility technique) with
brachial artery AI, a measure of arterial stiffness, in a rela-
tively young high-risk employee population.
Methods
The Baptist Employee Healthy Heart Study (BEHHS) is
a randomized controlled trial examining the efficacy of
an interactive internet-delivered program on reducing
metabolic risk in an employee population with diabetes
and/or metabolic syndrome (MS). The design and selec-
tion criteria for BEHHS have been described in detail
previously [14]. The results of this analysis are based on
the data from baseline visit of the study. The study
protocol was approved by the Baptist Health South Flor-
ida Institutional Review Board (IRB#13-028). All partici-
pants have provided written consent to participate in the
study.
The study measured lipoproteins using the ion mobility
technique, a gas chromatography technique that was
adapted to measuring subclasses of lipoproteins and has
been validated in several studies [15, 16]. Details of the
technique have also been previously described [17]. Aug-
mentation index as derived from peripheral arterial to-
nometry (endoPAT Itamar Medical Ltd., Israel) is
calculated from reflected pulse wave indices. It has shown
good test-retest reliability in subjects with metabolic syn-
drome in previous studies [18]. Because the AI is
dependent on the heart rate, it is normalized to a heart
rate of 75. The values provided are gender matched [19].
All statistical analyses were performed using STATA ver-
sion 13 statistical analysis package (StataCorp LP, College
Station, TX) [20]. Continuous variables were expressed as
means ± SD or median (interquartile range). Categorical
variables were represented by frequency and percentage.
Spearman Rank correlation coefficients were calculated for
each class of lipids with AI (continuous variable). The logis-
tic regression model (controlling for age and BMI) was used
to compute the odds ratios and 95% confidence interval
(CI), for an increase in AI with each standard deviation in-
crease in lipoprotein particle.
Results
The mean age of the 182 study participants was 52 ± 9
years with 74% women (n = 134) and 49% Hispanic popu-
lation. Across increasing quartiles of AI, there was a sig-
nificant trend with increasing age and a greater
proportion of females. By contrast, BMIs decreased with
higher AI (Table 1). HDL-c was the only traditional lipid
correlated with AI. Among the lipoprotein subclasses,
Spearman correlation showed that small IDL-p, total
HDL-p, small HDL-p, and large HDL-p were significantly
associated with AI (Table 2). Total cholesterol, large LDL-
p, and large IDL-p were also significantly correlated with
AI. Logistic regression analysis showed that increases in
total LDL-p, large LDL-p, small IDL-p, large IDL-p, total
HDL-p, small HDL-p, and large HDL-p were significantly
associated with increase in AI in the fully adjusted model.
Discussion
Our study findings, that associate higher LDL particles
(total and large) with AI, differ slightly from earlier stud-
ies which showed a significant positive association of
baPWV (a measure of arterial stiffness) with lipoprotein
subclasses of total LDL-p and small LDL-p in relatively
healthy population (age 40–49 years) [21] and with very
small LDL-p in patients with impaired glucose metabol-
ism [22]. The reason for these varied results among
these studies could be due to use of different methods to
examine the peripheral arterial stiffness and use of dif-
ferent laboratory techniques to measure the subclasses
of lipoproteins.
HDL particles do not follow traditional inverse rela-
tionship with CV risk factors, therefore complicating
proper assessment of the relative roles of distinct HDL
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Table 1 Descriptive characteristics of the study population along the quartiles of augmentation index (Al).
Variables [mean (SD) or %] All (n = 182) Q1 Q2 Q3 Q4 P trend
Age in years (SD) 51 (10) 46.26 (9.6) 49.42 (9.18) 52.97 (9.96) 55.91 (7.83) < 0.0001
% female 74 41.30 77.78 82.22 93.33 < 0.0001
Race
White 77.1 68.89 93.18 78.57 68.18 0.503
African American 16.6 26.67 4.55 11.90 22.73
Other 6.3 4.44 2.27 7.14 9.09
BMI [kg/m2] (SD) 34.2 (6) 37.20 (6.3) 35.20 (5.7) 33.11 (5.3) 31.26 (5.1) < 0.0001
SBP [mmHg] (SD) 134 (15.2) 132.52 (12.1) 133.38 (13.6) 134.64 (16.5) 137.09 (17.5) 0.343
DBP [mmHg] (SD) 83 (9.2) 84.06 (8.5) 82.53 (8.5) 82.36 (9.6) 82.02 (10.2) 0.288
Heart rate [HR] 73 (11) 72.39 (11.0) 74.58 (9.1) 74.38 (12.7) 70.76 (11.3) 0.278
Glucose [mg/dL] 105 (37.3) 99.20 (27.5) 106.53 (46.5) 114 (45.7) 100.17 (23.5) 0.325
CRP [mg/L] 6 (7.8) 7.24 (12.8) 5.81 (5.7) 6.26 (6.1) 4.08 (3.0) 0.355
% diabetes mellitus 29 21.74 37.78 31.11 24.44 0.950
% lifetime smoker 34 26.67 31.11 44.19 35.56 0.215
Physical activity [min/ day] 1.68 (0.5) 1.62 (0.5) 1.67 (0.5) 1.68 (0.5) 1.73 (0.5) 0.303
Values are expressed as means ± S.D. or percentages. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, Hs-CRP high-sensitivity
C-reactive protein
Table 2 Association of lipoprotein (LP) subclasses with augmentation index (Al) quartiles in study population (expressed as IQR)
AI continuous AI in ascending quartiles
Spearman
correlation
OR per SD increase in lipid/lipoprotein
Unadjusted Adjusted
TC [mg/dL] 0.1639* 1.30 (0.99–1.71) 1.21 (0.91–1.60)
TG-c [mg/dL] 0.0000 .99 (0.77–1.27) 0.97 (0.74–1.26)
HDL-c [mg/dL] 0.2298** 1.56 (1.19–2.04) 1.19 (0.89–1.60)
LDL-c [mg/dL] 0.0524 1.07 (0.82–1.40) 1.11 (0.84–1.46)
Non-HDL-c [mg/dL] 0.0755 1.18 (0.91–1.54) 1.23 (0.93–1.61)
Total LDL-p [nmol/L] 0.1093 1.31 (1.0–1.73) 1.42 (1.07–1.89)
Very Small LDL-p [nmol/L] 0.0150 1.18 (0.90–1.54) 1.27 (0.97–1.67)
Small LDL-p [nmol/L] 0.0133 1.12 (0.86–1.47) 1.26 (0.95–1.66)
Medium LDL-p [nmol/L] 0.0605 1.23 (0.93–1.61) 1.37 (1.03–1.82)
Large LDL-p [nmol/L] 0.1837* 1.44 (1.10–1.89) 1.40 (1.05–1.86)
Small IDL-p [nmol/L] 0.2643** 1.50 (1.13–1.98) 1.40 (1.05–1.87)
Large IDL-p [nmol/L] 0.1707* 1.41 (1.05–1.88) 1.49 (1.11–2.00)
Total HDL-p [nmol/L] 0.2747** 1.48 (1.10–1.99) 1.41 (1.03–1.94)
Small HDL-p [nmol/L] 0.2507** 1.45 (1.09–1.93) 1.40 (1.03–1.90)
Large HDL-p [nmol/L] 0.2658** 1.48 (1.10–2.00) 1.37 (1.00–1.89)
Small VLDL-p [nmol/L] 0.1203 1.32 (0.99–1.77) 1.43 (1.06–1.94)
Medium VLDL-p [nmol/L] 0.0451 1.19 (0.90–1.57) 1.30 (0.97–1.74)
Large VLDL-p [nmol/L] − 0.0052 1.13 (0.85–1.50) 1.16 (0.87–1.55)
Adjusted for age and BMI. Spearman ρ = Spearman rank correlation coefficient using Bonferroni significance level. Cut-off p value of p < 0.05 was used for
determining significance. Logistic regression models using 95% CI describe the change in AI per SD change in standardized values of lipoproteins. AI
augmentation index, LP lipoprotein, p particle number, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, IDL intermediate-density lipoprotein, HDL
high-density lipoprotein, VLDL very low-density lipoprotein
*p value ≤ 0.05
**p value ≤ 0.005
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particles in cardio-protection [15, 23, 24]. We discovered
that all subclasses of HDL showed a significant positive
association with AI in adjusted models. This finding was
not unique to our study as previous published papers
describe a positive relationship of HDL particles with AI
[21, 25, 26].
Neither triglycerides nor the triglyceride-rich VLDL
particles were associated with the AI in our study popu-
lation. The reasons for this unexpected lack of relation-
ship are not readily clear. Previous studies had shown
strong associations of VLDL particles with peripheral ar-
terial stiffness [21]. Our study showed a paradoxical
trend toward decreasing BMI with increasing AI. Our
study is not the first to report this negative association
of obesity with augmentation index [27]. For this reason,
we controlled for BMI in the lipoprotein statistical
analyses.
Our study is limited by the small sample size which di-
minishes the study’s power. The cross-sectional nature of
the study precludes conclusions on causality. The largely
Hispanic population also limits the generalizability of the
study’s findings. We only measured the association of
lipids with measures of peripheral arterial stiffness. The
inherent variability of the AI as a measure of overall vas-
cular function may indicate that comparison of different
methods of AI is needed to predict the association with all
classes of lipids.
Conclusions
In conclusion, our study shows that measures of lipopro-
tein subclasses are associated with increased peripheral
arterial stiffness as measured by AI in a high metabolic
risk population. Our study represents a step toward de-
termining the true relationship between lipids and arter-
ial stiffness. Once this relationship is clarified further,
pharmacological and lifestyle interventions can be stud-
ied in the context of their effect on levels of these lipo-
protein subclasses, with the aim of correcting these
abnormalities in time and potentially preventing further
CVD events.
Acknowledgements
The authors would like to thank all support personnel for their hard work
and dedication.
Authors’ contributions
MA, KN, and ECA contributed to the concept and design. MA and ECA
contributed to the analysis and interpretation. SG, US contributed to the
data collection. MA and CH contributed to the table formation. MA, CH, and
SG contributed to writing the article. KN contributed to the critical review of
article. MA, KN, and ECA contributed to final approval of article. The author(s)
read and approved the final manuscript.
Funding
No funding.
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
The study protocol was approved by the Baptist Health South Florida
Institutional Review Board (IRB 13-028). The study was also registered with
the ClinicalTrials.gov registry (registration no. NCT01912209). All participants
have provided written consent to participate in the study.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Author details
1Family Medicine Center, West Kendall Baptist Hospital, Miami, FL, USA.
2Center for Healthcare Advancement & Outcomes, Baptist Health South
Florida, 9555 SW 162nd Ave. MAB, Suite 103, Miami, FL 33196, USA. 3Florida
International University, Department of Humanities, Health, and Society
(HHS), Herbert Wertheim College of Medicine, Miami, FL, USA. 4Center for
Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven,
CT 06510, USA. 5Johns Hopkins University, Johns Hopkins Ciccarone Center
for Prevention of Heart Disease, Baltimore, MD, USA. 6Internal Medicine,
Section of Cardiovascular Medicine, Yale-New Haven Hospital, New Haven,
CT 06510, USA.
Received: 7 January 2020 Accepted: 25 February 2020
References
1. Hung CSLJ, Hsu CN, Chen HM, Tsai RY, Chien YF, Hwang JJ (2009) Using
brachial-ankle pulse wave velocity to associate arterial stiffness with
cardiovascular risks. Nutr Metab Cardiovasc Dis. 19(4):241–246. https://doi.
org/10.1016/j.numecd.2008.07.006 Epub Sep 23. PubMed PMID: 18815016
2. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009) Endothelial
dysfunction as a target for prevention of cardiovascular disease. Diabetes
Care. 32(Suppl 2):S314–SS21
3. Hadi HAR, Carr CS, Al SJ (2005) Endothelial dysfunction: cardiovascular risk
factors, therapy, and outcome. Vasc Health Risk Manag 1(3):183–198
4. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al (2001)
Aortic stiffness is an independent predictor of all-cause and cardiovascular
mortality in hypertensive patients. Hypertension. 37(5):1236–1241
5. Wykretowicz A, Adamska K, Guzik P, Krauze T, Wysocki H (2007) Indices of
vascular stiffness and wave reflection in relation to body mass index or
body fat in healthy subjects. Clin Exp Pharmacol Physiol. 34(10):1005–1009
6. Munir S, Guilcher A, Kamalesh T, Clapp B, Redwood S, Marber M et al (2008)
Peripheral augmentation index defines the relationship between central
and peripheral pulse pressure. Hypertension. 51(1):112–118
7. Fantin FMA, Bulpitt CJ, Banya W, Rajkumar C (2007) Elderly?, Is
augmentation index a good measure of vascular stiffness in the. Age
Ageing. 36(1):43–48 Epub 2006 Nov 17
8. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R et al (2004)
Arterial stiffness, wave reflections, and the risk of coronary artery disease.
Circulation. 109(2):184–189
9. Heffernan KS, Patvardhan EA, Hession M, Ruan J, Karas RH, Kuvin JT (2010)
Elevated augmentation index derived from peripheral arterial tonometry is
associated with abnormal ventricular-vascular coupling. Clin Physiol Funct
Imaging. 30(5):313–317
10. Sharman JE, Davies JE, Jenkins C, Marwick TH (2009) Augmentation index,
left ventricular contractility, and wave reflection. Hypertension. 54(5):1099–
1105
11. Woodman RJ, Kingwell BA, Beilin LJ, Hamilton SE, Dart AM, Watts GF (2005)
Assessment of central and peripheral arterial stiffness: studies indicating the
need to use a combination of techniques. Am J Hypertens. 18(2 Pt 1):249–
260
12. Zhao W, Gong W, Wu N, Li Y, Ye K, Lu B et al (2014) Association of lipid
profiles and the ratios with arterial stiffness in middle-aged and elderly
Chinese. Lipids Health Dis 13:37
Aziz et al. The Egyptian Heart Journal           (2020) 72:12 Page 4 of 5
13. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA
(1998) Relation of lipoprotein subclasses as measured by proton nuclear
magnetic resonance spectroscopy to coronary artery disease. Arterioscler
Thromb Vasc Biol.:1046–1053
14. Post JM, Ali SS, Roberson LL, Aneni EC, Shaharyar S, Younus A et al (2016)
Rationale and design of the Baptist Employee Healthy Heart Study: a
randomized trial assessing the efficacy of the addition of an interactive,
personalized, web-based, lifestyle intervention tool to an existing health
information web platform in a high-risk employee population. Trials. 17(1):1
15. Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC Jr et al (2007)
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the
Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 192(1):211–217
16. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE
et al (2009) Ion mobility analysis of lipoprotein subfractions identifies three
independent axes of cardiovascular risk. Arteriosclerosis, thrombosis, and
vascular biology. 29(11):1975–1980
17. Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH et al (2008)
Direct determination of lipoprotein particle sizes and concentrations by ion
mobility analysis. Clin Chem. 54(8):1307–1316
18. Sauder KA, West SG, McCrea CE, Campbell JM, Jenkins AL, Jenkins DJA et al
(2014) Test–retest reliability of peripheral arterial tonometry in the
metabolic syndrome. Diabet Vasc Dis Res 11(3):201–207
19. McCrea CE, Skulas-Ray AC, Chow M, West SG (2012) Test–retest reliability of
pulse amplitude tonometry measures of vascular endothelial function:
implications for clinical trial design. Vasc Med 17(1):29–36
20. Stata Statistical Software (2011) StataCorp. StataCorp LP, College Station
21. Vishnu ACJ, Masaki KH, Mackey RH, Barinas-Mitchell E, Shin C, Willcox BJ, El-
Saed A, Seto TB, Fujiyoshi A, Miura K, Lee S, Sutton-Tyrrell K, Kuller LH,
Ueshima H, Sekikawa A (2014) Group. EJS. Particle numbers of lipoprotein
subclasses and arterial stiffness among middle-aged men from the ERA
JUMP study. J Hum Hypertens. 28(2):111–117. https://doi.org/10.1038/jhh.
2013.60 Epub Jul 4. PubMed PMID: 23823580; PubMed Central PMCID:
PMC3800263
22. Takahashi R, Imamura A, Yoshikane M, Suzuki M, Murakami R, Cheng XW
et al (2010) Very small low-density lipoprotein cholesterol level is a
determinant of arterial stiffness in men with impaired glucose metabolism. J
Atheroscler Thromb. 17(12):1282–1289
23. Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD (2005) Insulin resistance
and adiposity influence lipoprotein size and subclass concentrations. Results
from the Insulin Resistance Atherosclerosis Study. Metabolism. 54(2):264–270
24. Jeyarajah EJ, Cromwell WC, Otvos JD (2006) Lipoprotein particle analysis by
nuclear magnetic resonance spectroscopy. Clin Lab Med. 26(4):847–870
25. Gallo LM, Silverstein JH, Shuster JJ, Haller MJ (2010) Arterial Stiffness,
Lipoprotein Particle Size, and Lipoprotein Particle Concentration in Children
with Type 1 Diabetes. J Pediatr Endocrinol Metab 23(7):661–667
26. Paynter NP, Sesso HD, Conen D, Otvos JD, Mora S (2011) Lipoprotein
subclass abnormalities and incident hypertension in initially healthy women.
Clin Chem 57:1178–1187
27. Tsuru T, Adachi H, Enomoto M, Fukami A, Kumagai E, Nakamura S et al
(2016) Augmentation index (AI) in a dose–response relationship with
smoking habits in males: The Tanushimaru study. Medicine. 95(51):e5368
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Aziz et al. The Egyptian Heart Journal           (2020) 72:12 Page 5 of 5
